Workshop report204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands

- An overview on the state-of-the-art of known and new biomarkers in DMD was presented.
- The strategies to identify biomarkers using standard and novel technologies were compared.
- The need to correlate outcome measures with biomarkers was established.
- The relevance of dystrophin as biomarker in clinical trials was pointed out.
- The importance of sharing data via registries and biorepositories was underlined.